Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI106183

Tissue iodoprotein formation during the peripheral metabolism of the thyroid hormones

Martin I. Surks, Harold L. Schwartz, and Jack H. Oppenheimer

1Endocrine Research Laboratory, Medical Division, Montefiore Hospital and Medical Center and the Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10467

Find articles by Surks, M. in: PubMed | Google Scholar

1Endocrine Research Laboratory, Medical Division, Montefiore Hospital and Medical Center and the Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10467

Find articles by Schwartz, H. in: PubMed | Google Scholar

1Endocrine Research Laboratory, Medical Division, Montefiore Hospital and Medical Center and the Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10467

Find articles by Oppenheimer, J. in: PubMed | Google Scholar

Published November 1, 1969 - More info

Published in Volume 48, Issue 11 on November 1, 1969
J Clin Invest. 1969;48(11):2168–2175. https://doi.org/10.1172/JCI106183.
© 1969 The American Society for Clinical Investigation
Published November 1, 1969 - Version history
View PDF
Abstract

The formation of tissue iodoproteins during the peripheral metabolism of the thyroid hormones was examined by determining the concentration of nonethanol-extractable 125I (NE125I) in various tissues after the intravenous injection of 3,5,3′-triiodo-L-thyronine (T3-125I) and L-thyroxine-125I (T4-125I) in groups of rats with iodide-blocked thyroid glands. 3 days after T3-125I and 7 days after T4-125I injection the concentration of NE125I in the liver and kidney was 5-10 times greater than in plasma. Smaller but nonetheless significant concentrations of NE125I were demonstrated in skeletal and cardiac muscle. Hepatic subcellular fractionation studies revealed that the major portion of the liver NE125I was in the microsomal fraction. Lower concentrations of NE125I were present in the nuclear, mitochondrial, and soluble fractions. When similar studies were performed in groups of rats pretreated with phenobarbital, an increase in the metabolic clearance of T3-125I (30%) and T4-125I (100%) was observed along with a highly significant increase in the NE125I concentration of the liver and plasma. The increase in hepatic NE125I in these studies was primarily due to the microsomal component.

Incubation of hepatic microsomes with T3-125I and T4-125I showed that NEI formation as well as deiodination appeared to obey simple Michaelis-Menten kinetics. Moreover, the maximal rate of both deiodination and NEI formation was increased when microsomes harvested from phenobarbital-treated rats were employed.

These studies indicate that thyroid hormone metabolism results in the formation of structural and soluble tissue iodoproteins in addition to circulating iodoproteins. The rate of formation of these moieties in the liver and plasma appears to be related to the rate of hormone metabolism.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 2168
page 2168
icon of scanned page 2169
page 2169
icon of scanned page 2170
page 2170
icon of scanned page 2171
page 2171
icon of scanned page 2172
page 2172
icon of scanned page 2173
page 2173
icon of scanned page 2174
page 2174
icon of scanned page 2175
page 2175
Version history
  • Version 1 (November 1, 1969): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts